Introduction & Objectives.- To evaluate the predictive factors for local failure with follow-up- biopsy after whole-gland salvage HIFU in local radio-recurrent PCa pts and to analyses the effects adverse following the therapy in terms of morbidity and quality of life on short-term. Materials and Methods.-From April 2006 to Sept 2010. Fifty-five pts with biopsy-proven localized radio-recurrent PCa and no distant metastasis, were subjected to whole- gland salvage HIFU using Sonablate®500. PSA levels, IPSS, IIEF-5, QoL and Adverse events (CTCAE) questionnaires were assessed at 45, 90, 180 days and 12 months respectivelly. Follow-up biopsy was done systematically at 180 days after treatment. The data was prospectively collected and retr...
BACKGROUND: Treatment options for radio-recurrent prostate cancer are either androgen-deprivation th...
peer reviewedIntroduction: Despite no consensus on the optimal management of recurrent prostate canc...
We report medium-term results in men receiving primary whole-gland HIFU (WG-HIFU) and following salv...
Introduction & Objectives.- To evaluate the predictive factors for local failure with follow-up- bio...
BACKGROUND: Prostate cancer (PCa) is the most commonly diagnosed malignancy in men and the second l...
Objective: To test high-intensity focused ultrasound (HIFU) as salvage first-line treatment for palp...
ABSTRACT Background Some men with localized radio-recurrent prostate cancer may benefit from salvag...
Objective To report the oncological outcome of salvage high-intensity focused ultrasound (S-HIFU) fo...
PURPOSE: To compare oncological, functional, and toxicity outcomes of patients with radiation-recurr...
International audienceOBJECTIVES: To determine the efficacy and adverse effects of high intensity fo...
Purpose: To evaluate tolerance and biochemical control rates of salvage external beam radiotherapy (...
OBJECTIVE: To assess short to medium term cancer control rates and side effects of focal salvage Hig...
Objective. - To report the oncological and functional outcomes of salvage hemiablation high-intensit...
Objectives: To evaluate the current status of focal therapy as the salvage treatment option for pati...
Objective To assess short- to medium-term cancer control rates and side effects of focal salvage hig...
BACKGROUND: Treatment options for radio-recurrent prostate cancer are either androgen-deprivation th...
peer reviewedIntroduction: Despite no consensus on the optimal management of recurrent prostate canc...
We report medium-term results in men receiving primary whole-gland HIFU (WG-HIFU) and following salv...
Introduction & Objectives.- To evaluate the predictive factors for local failure with follow-up- bio...
BACKGROUND: Prostate cancer (PCa) is the most commonly diagnosed malignancy in men and the second l...
Objective: To test high-intensity focused ultrasound (HIFU) as salvage first-line treatment for palp...
ABSTRACT Background Some men with localized radio-recurrent prostate cancer may benefit from salvag...
Objective To report the oncological outcome of salvage high-intensity focused ultrasound (S-HIFU) fo...
PURPOSE: To compare oncological, functional, and toxicity outcomes of patients with radiation-recurr...
International audienceOBJECTIVES: To determine the efficacy and adverse effects of high intensity fo...
Purpose: To evaluate tolerance and biochemical control rates of salvage external beam radiotherapy (...
OBJECTIVE: To assess short to medium term cancer control rates and side effects of focal salvage Hig...
Objective. - To report the oncological and functional outcomes of salvage hemiablation high-intensit...
Objectives: To evaluate the current status of focal therapy as the salvage treatment option for pati...
Objective To assess short- to medium-term cancer control rates and side effects of focal salvage hig...
BACKGROUND: Treatment options for radio-recurrent prostate cancer are either androgen-deprivation th...
peer reviewedIntroduction: Despite no consensus on the optimal management of recurrent prostate canc...
We report medium-term results in men receiving primary whole-gland HIFU (WG-HIFU) and following salv...